Search results
We’re on the road with a new approach to clinical trials—one that expands access to cutting-edge medicines and treatments. Lilly is a medicine company turning science into healing to make life better for people around the world.
We’re a medicine company turning science into healing to make life better for people around the world. Harnessing the power of biotechnology, chemistry and genetic medicine, our scientists are urgently advancing science to solve some of the world's most significant health challenges.
6 days ago · The announcement of an agreement for Lilly to acquire Morphic Holding, Inc. to expand Lilly's immunology pipeline with oral integrin therapies for treatment of serious chronic diseases; The commitment of an additional $5.3 billion manufacturing investment in the company's newest Indiana site to boost API production for tirzepatide and pipeline ...
Eli Lilly and Company is an American pharmaceutical company headquartered in Indianapolis, Indiana, with offices in 18 countries. Its products are sold in approximately 125 countries.
6 days ago · That compares with a profit of $1.76 billion, or $1.95 a share, a year earlier. Excluding one-time items associated with the value of intangible assets and other adjustments, Eli Lilly posted ...
For more than 145 years, we have worked tirelessly to develop and deliver trusted medicines and diagnostics that meet real needs. Our growing portfolio of medicines includes treatments in the areas of bone muscle joint, cancer, cardiovascular, diabetes, endocrine, immunology, neuroscience and obesity. The product information on this website is ...
5 days ago · Aug 8 (Reuters) - Increased manufacturing capacity for Eli Lilly's (LLY.N) highly sought after weight-loss drug Zepbound drove the company to raise its annual sales forecast by $3 billion on ...
FDA approves Lilly's Mounjaro™ (tirzepatide) injection, the first and only GIP and GLP-1 receptor agonist for the treatment of adults with type 2 diabetes. May 13, 2022. Download PDF. Mounjaro delivered superior A1C reductions versus all comparators in phase 3 SURPASS clinical trials.
5 days ago · Lilly also hiked its forecast for the year well beyond Wall Street expectations as newer drugs like Zepbound built momentum. The company’s shares soared Thursday after Lilly detailed its quarterly results. Mounjaro sales more than tripled in the quarter to nearly $3.1 billion.
5 days ago · Listen. 3:12. Eli Lilly & Co. is narrowing the gap with rival Novo Nordisk A/S in the race to dominate the red-hot obesity market as it expands its supplies of weight-loss drugs. Sales of the ...
